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Hexaene Derivatives of Nystatin Produced as a
Result of an Induced Rearrangement within the nysC
Polyketide Synthase Gene in S. noursei ATCC 11455
condensations of the simple carboxylic acids, resulting
in the assembly of a polyketide chain, which is cyclized
to form a macrolactone ring [3]. The conjugated double
bonds on the macrolactone rings of polyenes apparently
arise due to the reductive activities of specific domains
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N-7491 Trondheim embedded in the PKSs. Further modification of the poly-
ene macrolactone ring via the action of monooxygen-2 SINTEF Applied Chemistry
SINTEF ases and glycosyltransferases leads to the formation of
a fully biologically active molecule [4]. Recently, a firstN-7034 Trondheim
3 Institute for Cancer Research report on the engineered biosynthesis of a novel deriva-
tive of the polyene antibiotic pimaricin has been pub-and Molecular Biology
Norwegian University of Science and Technology lished [5]. The data presented in this work confirm the
importance of post-PKS modifications for the biologicalN-7489 Trondheim
Norway activity of polyenes and provide further insight into the
structure-function relationship of the polyene antibi-
otics.
The properties of PKSs involved in the biosynthesisSummary
of macrolide antibiotics make it possible to change their
structure and embedded enzymatic activities in suchGenetic manipulation of the polyketide synthase (PKS)
a way that new compounds with predictable chemicalgene nysC involved in the biosynthesis of the tetraene
structures can be produced [6]. From this point of view,antifungal antibiotic nystatin yielded a recombinant
the PKSs involved in the biosynthesis of polyene macro-strain producing hexaene nystatin derivatives. Analy-
lide antibiotics are excellent targets for manipulationsis of one such compound, S48HX, by LC-MS/MS sug-
that may provide novel antifungal agents with improvedgested that it comprises a 36-membered macrolac-
pharmacological properties.tone ring completely decorated by the post-PKS
The antibiotic nystatin, which is commonly used asmodification enzymes. Further characterization by
an antifungal agent for the treatment of mycoses, is abioassay has shown that S48HX exhibits antifungal
member of the polyene macrolide group. This antibioticactivity. Genetic analysis of the hexaene-producing
is a rather unique tetraene in the sense that it has setsmutant revealed an in-frame deletion within the nysC
of two and four conjugated double bonds (the former notgene via recombination between two homologous
being considered a polyene feature) on its macrolactoneketoreductase domain-encoding sequences. Appar-
ring that are separated by a fully saturated bond (Figureently, this event resulted in the elimination of one com-
1). We have recently cloned and sequenced the nystatinplete module from NysC PKS, subsequently leading
biosynthetic gene cluster from the producing organismto the production of the nystatin derivative with a con-
S. noursei ATCC 11455 and proposed the complete bio-tracted macrolactone ring. These results represent the
synthetic pathway for this antibiotic [7]. Analysis of thefirst example of manipulation of a PKS gene for the
gene cluster revealed that six polyketide synthase pro-biosynthesis of a polyene antibiotic.
teins are responsible for the formation of the nystatin
macrolactone ring and the appearance of the conju-
Introduction gated double bonds. Taking advantage of this knowl-
edge, we decided to genetically manipulate the nystatin
The number of antifungal antibiotics currently available PKS in order to produce novel antifungal antibiotics. In
for human therapy is severely limited. The polyene mac- the current report, we describe an integration-induced
rolides represent a subgroup of polyketide antibiotics rearrangement within the nystatin PKS gene in S. noursei
with potent antifungal activity due to their ability to inter- that leads to the production of a hexaene nystatin deriva-
act with ergosterol in the fungal membranes, leading to tive with antifungal activity.
the formation of transmembrane channels, ion leakage,
and cell lysis [1]. Polyene antibiotics have large 20- to Results
40-membered macrolactone rings with chromophores
composed of sets of 3–8 conjugated double bonds. It Inactivation of the ER Domain in Module 5
is suggested that the conjugated double bonds play a of the NysC PKS
crucial role in the polyene-sterol interactions and thus The enoyl reductase (ER) domain in module 5 of the
are important for the antifungal activity [2]. NysC PKS is apparently responsible for the appearance
Most of the polyene macrolide antibiotics are pro- of a fully saturated bond between C-28 and C-29 on the
duced by the Gram-positive bacteria Streptomyces via nystatin molecule (Figure 1). Thus, by inactivating this
biosynthetic routes that involve modular polyketide syn- particular domain, it is theoretically possible to obtain
thases (PKSs). The latter enzymes perform successive a compound with a double bond between C-28 and
C-29, thus joining two sets of conjugated double bonds
in the nystatin molecule and creating a heptaene macro-4 Correspondence: sergey.zotchev@chembio.ntnu.no
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Figure 1. Role of the NysC PKS in the Biosynthesis of the Nystatin Macrolactone Ring
KS: -ketoacyl synthase, AT: acyl transferase, DH: dehydratase, ER: enoyl reductase, KR: ketoreductase, ACP: acyl carrier protein.
lide compound. To perform such an inactivation, the of C-28 and C-29 methylene functions in the nystatin
molecule, leading to a joining of the two sets of conju-method of “in-frame” deletion by double homologous
gated double bonds.recombination using the suicide plasmid pERD4.2 (see
Theoretically, the fully post-PKS-modified hexaenethe Experimental Procedures) was chosen. A gene re-
product of the ERD48 mutant should have a molecularplacement procedure resulted in isolation of the mutant
weight of 897.6, corresponding to nystatin (MW 925.6)ERD44 that, according to Southern blot analysis, con-
minus a CH2-CH2 moiety (MW 28). This molecular weighttained the desired deletion eliminating a major portion
difference is referred to below as28. Methanol extractsof the ER5 domain-coding region within the nysC gene
of the ERD48 and WT cultures were subjected to LC-(data not shown). Preliminary analysis of the ERD44 mu-
diode array detector (DAD)-MS analysis, which showedtant revealed that it did not produce nystatin, although
that ERD48 produced a mixture of hexaene compoundspolyene compounds with UV spectra characteristic for
(Figure 2B), while no hexaene-like substances were pro-heptaens [8] were detected (data not shown). However,
duced by the WT strain (data not shown). The molecularwe have also detected traces of the heptaene-like com-
weights for the compounds represented by three majorpound in the extract of the wild-type (WT) strain in addi-
peaks are given in the DAD plot. The molecular weighttion to nystatin (P.B., unpublished data). Because of
of the compound eluting at 16 min (MW 897.6) corre-that, and the low yield of the heptaene-like compound
sponds to a 36-membered macrolactone ring com-produced by the ERD44 mutant, the latter was not con-
pletely decorated by the post-PKS modification en-sidered for further analysis during this study (also see
zymes. This novel compound was designated S48HX.the Discussion).
Furthermore, the molecular weight 736.6 for the hexaene
compound eluting at 7.5 min suggests that it represents
a precursor of S48HX, which lacks both the C-10 hy-
Deletion of One Complete Module from the NysC
droxyl and the C-19 mycosamine moiety. The third com-
PKS Leads to the Production pound with molecular weight 752.6 eluting at 6.5 min is
of Hexaene Compounds presumably an S48HX precursor lacking only the myco-
During the screening for the ER5 deletion, a mutant samine moiety. Thus, it appears that the post-PKS modi-
ERD48 was isolated, which, according to the Southern fication of the hexaene aglycone produced by the
blot analysis, contained a larger deletion compared to ERD48 mutant proceeds at a variable extent, reflecting
the ERD44 strain (data not shown). Surprisingly, UV- the specificity of the decorating enzymes toward the
absorption spectra of DMSO extract of the ERD48 cul- new substrate.
ture revealed an upward shift of about 60 nm compared Extracts of the ERD48 and WT cultures were also
to that of the wild-type culture extract containing ny- subjected to LC-DAD-MS/MS analysis. The iontrap-iso-
statin (Figure 2A). The characteristic absorption spectra lated parent ions were fragmented in an automatic mode
of polyenes are shifted according to the number of con- with a range of fragmentation amplitudes assuring opti-
jugated double bonds, and the three-peak absorption in mal fragmentation conditions. Representative fragmen-
the 340–380 nm range of the ERD48 extract is consistent tation patterns for the S48HX compound and nystatin
with a hexaenic structure of the conjugated region on are given in Figures 3A and 3B, respectively. A total of
the polyene polyketide molecule [8]. For compounds 11 major S48HX fragments (878.5, 816.5, 810.5, 799.5,
635.3, 617.5, 588.5, 407.3, 394.3, 341.3, and 305.3) couldproduced by ERD48, this could be explained by a loss
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Figure 2. Analysis of Metabolites Produced
by the S. noursei Wild-Type and ERD48
Strains
(A) A UV scan of DMSO extracts of S. noursei
ATCC 11455 and ERD48 strains.
(B) Diode-array HPLC data for the ERD48 cul-
ture extract. Molecular weights (MW) for three
major compounds determined by LC-MS/MS
are indicated (see text for details).
be correlated by 28 to 11 major nystatin fragments a hybrid PKS module, consistent with recombination
between DNA sequences encoding the highly homolo-(906.5, 844.5, 838.6, 827.5, 663.5, 645.5, 616.4, 435.1,
422.2, 369.1, and 333.3). These 11 peaks are interpreted gous KR domains in modules 4 and 5 of NysC. This
recombination has apparently led to a deletion of theas fragments of S48HX including the region with conju-
gated double bonds, which explains the difference in DNA sequences encoding the C-terminal part of the KR
domain and the complete ACP domain of module 4, andmass of 28 compared to the nystatin fragments. There-
fore, both the UV spectrum and fragmentation analysis the KS, AT, DH, ER, and N-terminal part of the KR domain
of module 5, thus resulting in the loss of one completeof S48HX tentatively suggest the structure of S48HX
presented in Figure 3C. module from the NysC PKS (Figure 4). Based on the
above data, we were able to predict the organizationProduction of the S48HX compound by the ERD48
mutant would be consistent with an “in-frame” deletion of the truncated version of NysC protein (NysC48) in
ERD48 (Figure 4), which is in agreement with the produc-of a DNA fragment encoding one complete module of
the NysC PKS. In order to investigate this hypothesis in tion of hexaene nystatin derivatives by this mutant.
more detail, a PCR-amplification of the DNA fragment
encompassing the suggested deletion was carried out Purification and Antifungal Activity
of the S48HX Compoundfrom the genomes of both ERD48 and the WT strains
(see the Experimental Procedures). As expected, a 9.0- A polyene fraction containing95% S48HX was purified
from the ERD48 culture extract by preparative reverse-kb fragment (including the entire module 5) was ampli-
fied from the genome of the S. noursei WT, while an phase HPLC and reverse-phase solid phase extraction
(data not shown). The extinction coefficient (E1%1cm) of 14992.7-kb fragment was amplified from the ERD48 ge-
nome (data not shown). Cloning and DNA sequencing (379-nm peak) was experimentally determined for this
fraction. This value was used to calculate the level ofof the latter fragment confirmed that it encodes part of
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Figure 3. Preliminary Structural Characterization of the Hexaene Nystatin Derivative S48HX
(A and B) Fragmentation patterns for the (A) S48HX compound and (B) nystatin obtained during LC-MS/MS analysis of the culture extracts
from the ERD48 mutant and the WT strain, respectively. Fragments correlated by 28 and described in the Results are indicated with arrows.
(C) Proposed planar chemical structure of the S48HX compound.
S48HX production by the ERD48 mutant, which consti- was assessed in a bioassay using Candida albicans
ATCC 10231 as a test organism (see the Experimentaltuted approximately 1.2 g/l. In the same conditions, the
level of nystatin production by the wild-type Streptomy- Procedures). According to our results, the MIC50 for
S48HX was shown to be 19.9 g/ml, while the MIC50 forces noursei was 4–5 g/l. The antifungal activity of the
purified S48HX compound, along with that of nystatin, nystatin in the same experiment was found to be 0.7
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Figure 4. Model Explaining the Generation of
the ERD48 Mutant
After integration of the pERD4.2 vector into
the nysC gene, a second crossover between
highly homologous KR4- and KR5-encoding
sequences might take place. This event re-
sults in the elimination of one complete mod-
ule from the NysC PKS (NysC48).
g/ml. The antifungal activity of S48HX is therefore ap- Fortuitously, integration of the plasmid designed for
the ER5 inactivation into S. noursei and its subsequentproximately 30 times lower than that of nystatin.
elimination via second crossover led to the generation
of another mutant, ERD48, producing hexaene nystatinDiscussion
derivatives. From the DNA sequencing data, it became
clear that a homologous recombination had occurredGenetic manipulation of polyketide synthases is a prom-
between the DNA fragments encoding the KR4 and KR5ising strategy for extending the diversity of the naturally
domains within the nysC gene disrupted by the vector,occurring polyketide compounds [6]. With the aim of
leading to a perfect “in-frame” deletion of one completecreating novel derivatives of the polyene antibiotic ny-
PKS module. These DNA fragments indeed share 99.9%statin, we have attempted to modify the nystatin PKS
sequence identity over the entire KR-encoding regionsNysC in the producing organism S. noursei. Originally,
(742 nt) and most probably represent a case of a rela-our aim was to produce a heptaene nystatin derivative
tively recent duplication in the process of the nystatinvia inactivation of the ER domain in module 5 of NysC
gene’s evolution. Moreover, the G  C content of KR4-that would be responsible for the formation of the satu-
and KR5-encoding DNA is substantially lower than thatrated bond between C-28 and C-29. The resulting mu-
of the rest of the nystatin gene cluster (65% versustant ERD44 did not produce nystatin; although, traces
74%), suggesting that this sequence was acquired fromof heptaene compounds were detected in the culture
another organism with lower G  C content. It seemsextracts. Upon the detailed analysis of the extracts from
likely that the recombination event that yielded thethe WT S. noursei, we have also detected traces of a
ERD48 mutant was triggered by the integration of theheptaene compound that disappeared upon insertional
gene replacement vector into this particular region ofinactivation of the nystatin PKS genes (S.B.Z. and H.S.,
the nysC gene and that an alternative second crossoverunpublished data). We are currently trying to understand
took place according to the model presented in Figurethe mechanisms behind this phenomenon with regard
4. This notion is supported by the fact that the hexaene-to nystatin biosynthesis by studying the heptaene bio-
synthesis in both WT and ERD44 S. noursei strains. producing S. noursei strain was never found during the
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previous extensive screening (E. Fjærvik and H.S., un- fies its biosynthesis. Characterization of the mutant
producing the hexaene nystatin derivative providespublished data). The data presented above support the
hypothesis on PKS evolution in Streptomyces that pro- insight into the possible routes for the evolution of
PKSs and paves the way for rational manipulation ofposes the acquisition of new modules brought in by
mobile genetic elements, their integration into the PKS- the nystatin PKS with the aim of high-yield production
of novel polyene antibiotics.encoding genes, and later rearrangement [9]. In this
respect, the finding of IS-like elements in several PKS-
Experimental Proceduresencoding gene clusters [10, 11] might be of significant
value to support this hypothesis.
Strains, Plasmids, and Growth Conditions
The molecular weight of the new hexaene nystatin S. noursei strains were maintained on solid agar medium ISP2 (Difco)
derivative S48HX produced by the ERD48 mutant is con- at 30C. For total DNA isolation from S. noursei strains, the liquid
sistent with the fully modified 36-membered macrolide, medium TSB (3%, Oxoid) was used. The Escherichia coli strains
DH5 and XL1-Blue were grown and manipulated as describedsuggesting a substantial tolerance of the post-PKS en-
elsewhere [14]. DNA transfer to S. noursei was accomplished viazymes toward the new substrate. The LC-MS/MS frag-
conjugation from the E. coli ET12567 (pUZ8002) strain according tomentation patterns for S48HX also are in agreement
the procedure established earlier [11]. The recombinant phage N45
with the structural formula suggested for this compound [7] served as a template for PCR-assisted construction of a gene
(Figure 3C). The antifungal activity of S48HX was shown replacement plasmid. The vector pGEM3Zf() (Promega) was uti-
to be lower compared to nystatin, implying that not only lized for general cloning, while pSOK201 vector [11] was used for
construction of the conjugative gene replacement plasmid. Fermen-a number of conjugated double bonds, but also the
tation of the WT and recombinant S. noursei strains as well assize of a macrolactone ring, might be important for the
the gene replacement procedure were carried out essentially asbiological activity. Nevertheless, the real pharmaceuti-
described earlier [15]. Candida albicans ATCC 10231 used as a
cal value of the S48HX compound can be assessed only test organism for measuring antifungal activity was purchased from
upon studying its cytotoxicity and other possible effects ATCC and was maintained according to recommendations from the
on the biological systems. supplier.
The fact that post-PKS modification enzymes can rec-
DNA Manipulation and Sequencingognize and process contracted nystatin macrolactone
DNA manipulation was performed essentially according to Sam-rings further confirms the relaxed substrate specificity
brook et al. [14]. The DNA sequencing was carried out at QIAGENfor macrolide aglycone-decorating enzymes. It has been
GmbH (Germany).
shown previously that certain glycosyltransferases and
hydroxylases are quite tolerant of changes in the macro- Construction of the pERD4.2 Vector and the Gene
lactone substrate [12, 13]. Data for the ERD48 mutant Replacement Procedure
PCR-assisted amplification of a 394-bp DNA fragment representingimply that at least three enzymes in the nystatin biosyn-
the coding sequence for the C-terminal part of the ER domain andthetic pathway, monooxygenases NysL and NysN, and
the N-terminal part of the KR domain in module 5 of NysC wasputative mycosamine transferase NysDI, have rather re-
performed. Two primers were used: ERD1 (5	-GTTGGTACCCCACT
laxed substrate specificities. The degree of such flexibil- CCCGGTCCGCAC-3	, sense) and ERD2 (5	-CCAGCCGCATGCAC
ity for the nystatin aglycone modification enzymes is CACC-3	, antisense), with KpnI and SphI restriction enzyme cleav-
reflected in the metabolite profile of the ERD48 mutant age sites, respectively (underlined). The resulting PCR fragment was
digested with KpnI and SphI and ligated together with the 1828-bp(Figure 2B). All three major polyene compounds pro-
BamHI/KpnI DNA fragment (encompassing the DH4-coding regionduced by this mutant seem to contain a carboxy group
of nysC) and the 1273-bp SphI/EcoRI DNA fragment (encompassingat C-16, suggesting that a monooxygenase responsible
the KR5-, ACP5-, and KS6-encoding segments of nysC) into the
for this reaction has relaxed substrate specificity. The EcoRI/BamHI-digested pGEM3Zf() vector. The recombinant plas-
NysDI, putative mycosamine transferase, and C-10 hy- mid of 6.7 kb designated pERD4.1, which contained a hybrid DNA
droxylase, however, do not seem to possess the same fragment with an “in-frame” deletion in the NysC-coding region, was
recovered. This deletion eliminated the coding region for the parttolerance toward the substrate, as more than half of the
of the DH-ER interdomain linker and the N-terminal part of the ERpolyene compounds produced by ERD48 are repre-
domain containing a putative NADP(H) binding site (aa 4829–5200sented by S48HX aglycone lacking the C-10 hydroxyl.
of NysC). From pERD4.1, the 3.7-kb EcoRI/HindIII insert was excised
Besides raising interesting issues on the enzyme-sub- and ligated with the 3.0-kb EcoRI/HindIII DNA fragment from plasmid
strate interactions in the antibiotic biosynthesis, these pSOK201, resulting in the pERD4.2 construct.
data might also be useful in the future design of the
experiments aimed at the production of novel nystatin PCR-Assisted Amplification and Cloning of the PKS-
Encoding DNA Fragment from the S. nourseiderivatives.
ERD48 Genome
The PCR reaction aimed at amplification of the part of the rearranged
region of the nysC gene in S. noursei ERD48 was carried out withSignificance
oligonucleotide primers KR48.1 (5	-CCGCGTCGGATCCGCCGAC-3	)
and KR48.2. (5	-AGCCTTCGAATTCGGCGCC-3	), which were de-
Polyene antibiotics are the drugs of choice for fighting rived from the DH4- and KS6-coding sequences of nysC and encom-
passed BamHI and EcoRI restriction sites, respectively (underlined).fungal infections. However, their use for treatment of
The 50 l PCR mixture contained 0.1 g S. noursei ERD48 totalsystemic mycoses is limited due to their relatively high
DNA, 25 pmol of each primer, dNTPs (350 m), 1
 PCR buffer fromtoxicity. Thus, there is a need for new polyene antibiot-
Expand High Fidelity PCR System (Roche Molecular Biochemicals),ics with improved pharmacological properties. In the
and 1.5 U of the DNA polymerase mixture from the same system.
current study, we demonstrate the production of novel The PCR was performed on the Perkin Elmer GeneAmp PCR System
derivatives of the polyene antibiotic nystatin as a result 2400 with the following program: 1 cycle of denaturation at 96C (4
min), 35 cycles of denaturation at 94C (45 s) and annealing/synthe-of the rearrangement within the PKS gene that speci-
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sis at 70C (10 min), and 1 cycle of final annealing/synthesis at 72C 3. Donadio, S., Staver, M.J., McAlpine, J.B., Swanson, S.J., and
Katz, L. (1991). Modular organization of genes required for com-(10 min). The 2.7-kb DNA fragment obtained with this procedure
was digested with EcoRI and BamHI restriction enzymes and ligated plex polyketide biosynthesis. Science 252, 675–679.
4. Gil, J.A., and Martin, J.F. (1997). Polyene antibiotics. In Biotech-with pGEM3Zf() vector DNA digested with the same enzymes. The
resulting plasmid, pKR48, was subjected to DNA sequence analysis. nology of Antibiotics, W.R. Strohl, ed. (New York: Marcel Dek-
ker), pp. 551–575.As a control, PCR amplification with the same primers was per-
formed using the S. noursei ATCC 11455 DNA as a template. 5. Mendes, M.V., Recio, E., Fouces, R., Luiten, R., Martin, J.F., and
Aparicio, J.F. (2001). Engineered biosynthesis of novel polyenes:
a pimaricin derivative produced by targeted gene disruption inCharacterization of the Nystatin Derivatives
Streptomyces natalensis. Chem. Biol. 8, 635–644.Cell pellets from 1-ml cultures were extracted with 10 ml methanol
6. Katz, L., and McDaniel, R. (1999). Novel macrolides throughfor 1 hr. After centrifugation, the methanol phase was applied di-
genetic engineering. Med. Res. Rev. 19, 543–558.rectly both to the analytical and preparative LCs. The LC-DAD-
7. Brautaset, T., Sekurova, O.N., Sletta, H., Ellingsen, T.E., Strøm,MS/MS analysis was carried out using the Agilent 1100 series LC/
A.R., Valla, S., and Zotchev, S.B. (2000). Biosynthesis of theMSDTrap system. The LC was operated as a gradient system at a
polyene antibiotic nystatin in Streptomyces noursei ATCCflow rate of 0.3 ml min1. Eluent A contained 30% acetonitrile and
11455: analysis of the gene cluster and deduction of the biosyn-1.4% tetrahydrofuran in MilliQ water, and the pH was adjusted to
thetic pathway. Chem. Biol. 7, 395–403.4.0 by 1 M acetic acid. Eluent B was pure acetonitrile. The initial
8. Omura, S., and Tanaka, H. (1984). Production, structure, andconditions were 100% A (20 min), 40% B (25 min), and 100% B for
antifungal activity of polyene macrolides. In Macrolide Antibiot-10 min. A Waters Nova-Pak C18 2 
 150-mm column was used.
ics: Chemistry, Biology, and Practice, S. Omura, ed. (New York:The Iontrap mass spectrometer was operated with the electrospray
Academic Press), pp.351–405.ionization source in the negative ion mode. Drying gas flow was 8
9. Hopwood, D.A. (1997). Genetic contributions to understandingl/min, and nebulizer pressure was 30 psi. Drying gas temperature
polyketide synthases. Chem. Rev. 97, 2465–2497.was 350C; Skim1  59.7V, the cap exit offset  87.2V, and the
10. Donadio, S., and Staver, M.J. (1993). IS1136, an insertion ele-trap drive setting 69.1. During auto MS/MS experiments of eluting
ment in the erythromycin gene cluster of Saccharopolysporaparent ions, the fragmentation amplitude was varied between 0.6
erythraea. Gene 126, 147–151.and 1.5V.
11. Zotchev, S.B., Haugan, K., Sekurova, O., Sletta, H., Ellingsen,
T.E., and Valla, S. (2000). Identification and partial characterisa-Preparative HPLC and Bioassay
tion of the gene cluster governing biosynthesis of a novel anti-The preparative HPLC system consisted of a manual sampling port,
bacterial polyketide-derived antibiotic in Streptomyces nourseia Waters pump, a Shimadzu UV analyzator set at 370 nm, and a
ATCC 11455. Microbiology 146, 611–619.Pharmacia fraction collector. A Waters Nova-Pak C18 3.9 
 300-mm
12. Graziani, E.I., Cane, D.E., Betlach, M.C., Kealey, J.T., and Mc-column was used with a flow rate of 8 ml/min. The preparative LC
Daniel, R. (1998). Macrolide biosynthesis: a single cytochromewas run isocratically with the mobile phase identical to eluent A
P450, PicK, is responsible for the hydroxylations that generate(see above) supplemented with 0.1 g/l EDTA (pH was adjusted to
methymycin, neomethymycin, and picromycin in Streptomyces4.0 with 1 M acetic acid). Fractions (8 ml) were collected, and S48HX
venezuelae. Bioorg. Med. Chem. Lett. 8, 3117–3120.fractions from run 25 were pooled and diluted in the same volume
13. Tang, L., and McDaniel, R. (2001). Construction of desosamineof MilliQ water. A buffer change and concentration step were per-
containing polyketide libraries using a glycosyltransferase withformed with solid phase extraction using Waters Nova-Pak C18 3-ml
broad substrate specificity. Chem. Biol. 8, 547–555.200-mg matrix columns, and the pure S48HX compound was eluted
14. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecularwith methanol. The methanol was further evaporated on a Speed-
Cloning: A Laboratory Manual, Second Edition (Cold Spring Har-Vac, and the sample was redissolved in a lower volume of methanol
bor, NY: Cold Spring Harbor Laboratory Press).prior to bioactivity testing. The S48HX fraction was analyzed with
15. Sekurova, O., Sletta, H., Ellingsen, T., Valla, S., and Zotchev, S.B.the analytical LC-DAD system, and the purity was estimated by area
(1999). Molecular cloning and analysis of a pleiotropic regulatorycomparison of all significant peaks to be 95%.
gene locus from the nystatin producer Streptomyces nourseiBioactivity testing of S48HX was performed in 96-well plates with
ATCC 11455. FEMS Microbiol. Lett. 177, 297–304.120 l TSB medium (3%, Oxoid) and 500 CFU of Candida albicans
ATCC 10231 per well. A total of 30 l of sample was added in
Accession Numbersappropriate dilutions. The plates were incubated for 16–20 hr at
30C on a rotary shaker, and the OD490 was measured. Nystatin
The DNA sequence for the PCR fragment amplified from thetreated in the same manner with solid phase extraction and solvent
S. noursei ERD48 genome was deposited into the GenBank underevaporation was used as a standard.
the accession number AF420594.
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